Table 2 Antihypertensive drugs in use at the end of the trial

From: Impact of renal function on cardiovascular events in elderly hypertensive patients treated with efonidipine

 

Baseline eGFR⩾60 (n=1917)

Baseline eGFR <60 (n=2499)

 

Strict treatment group (n=981)

Mild treatment group (n=936)

P-value

Strict treatment group (n=1230)

Mild treatment group (n=1269)

P-value

Efonidipine monotherapy

684 (69.7)

721 (77.0)

<0.001

885 (72.0)

985 (77.6)

0.001

ACE inhibitors/ARB

175 (17.8)

117 (12.5)

0.001

227 (18.5)

152 (12.0)

<0.001

Other Ca channel blockers

20 (2.0)

12 (1.3)

0.20

21 (1.7)

17 (1.3)

0.45

Adrenoceptor blockers

49 (5.0)

47 (5.0)

0.98

78 (6.3)

69 (5.4)

0.34

Diuretics

84 (8.6)

36 (3.8)

<0.001

84 (6.8)

60 (4.7)

0.02

Others

2 (0.2)

0 (0.0)

0.17

6 (0.5)

3 (0.2)

0.29

None

62 (6.3)

57 (6.1)

0.84

56 (4.6)

67 (5.3)

0.40

  1. Abbreviations: ACE, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker.
Back to article page